FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($1.04), $0.45 worse than the analyst estimate of ($0.59).
"Amidst an incredibly challenging economic landscape, I am pleased to report Arcadia has achieved a number of key milestones across each of the crop product areas in which we innovate: hemp, wheat and soy," said Matthew Plavan, president and CEO of... More

